101
|
Karasawa K, Shimizuguchi T, Murata H, Kageyama S, Tanaka H, Machitori Y, Chang T, Fujii M, Nihei K, Hanyu N. Radioactive Treatment in Patients With Metastatic Well-Differentiated Thyroid Cancer. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.1220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
102
|
Karasawa K, Machitori Y, Shimizuguchi T, Murata H, Kageyama S, Tanaka H, Chang T, Fujii M, Nihei K, Hanyu N. Three-Dimensional Non-Coplanar Conformal Radiation Therapy With 75 Gy/25fr/5w Regimen for the Treatment of Stage I NSCLC: A 10-year Experience. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.1456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
103
|
Yamashina T, Uedo N, Fujii M, Ishihara R, Mikamori M, Motoori M, Yano M, Iishi H. Delayed perforation after intralesional triamcinolone injection for esophageal stricture following endoscopic submucosal dissection. Endoscopy 2013; 45 Suppl 2 UCTN:E92. [PMID: 23526537 DOI: 10.1055/s-0032-1326253] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
104
|
Ishii M, Fujii M. Depth percept from motion parallax by backward/forward head movements. J Vis 2013. [DOI: 10.1167/13.9.1180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
105
|
Kochi M, Fujii M, Kanamori N, Kaiga T, Okubo R, Mihara Y, Takayama T. Pharmacokinetics of Oxaliplatin in Gastrointestinal Cancer Patients with Malignant Ascites. J Chemother 2013; 23:28-31. [DOI: 10.1179/joc.2011.23.1.28] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
106
|
Malhotra R, Usyvat L, Raimann J, Thijssen S, Levin N, Kotanko P, Hilderman M, Qureshi AR, Al-Abed Y, Anderstam B, Bruchfeld A, Minco M, Argentino G, Grumetto L, Postiglione L, Memoli B, Riccio E, Striker G, Yubero-Serrano E, Uribarri J, Vlassara H, do Sameiro-Faria M, Ribeiro S, Kohlova M, Rocha-Pereira P, Fernandes J, Nascimento H, Reis F, Miranda V, Bronze-da-Rocha E, Quintanilha A, Costa E, Belo L, Santos-Silva A, Modilca M, Margineanu M, Gluhovschi G, Vernic C, Velciov S, Petrica L, Barzuca E, Gluhovschi C, Balgradean C, Kaycsa A, Stockler-Pinto M, Dornelles S, Cozzolino S, Malm O, Mafra D, Cobo G, Rodriguez I, Oliet A, Hinostroza J, Vigil A, Di Gioia M, Gallar P, Drechsler C, Wanner C, Blouin K, Pilz S, Tomaschitz A, Krane V, Marz W, Ritz E, van der Harst P, de Boer R, Carrero JJ, Cabezas-Rodriguez I, Zoccali C, Qureshi A, Ketteler M, Gorriz J, Rutkowski B, Teplan V, Kramar R, Pavlovic D, Goldsmith D, Benedik M, Fernandez-Martin J, Cannata-Andia J, Guido G, Loiacono E, Serriello I, Camilla R, Coppo R, Amore A, Schiller A, Munteanu M, Schiller O, Mihaescu A, Olariu N, Andrei C, Anton C, Ivacson Z, Roman V, Berca S, Bansal V, Marcelli D, Grassmann A, Bayh I, Scatizzi L, Marelli C, Etter M, Usvyat L, Kooman J, Sande F, Levin N, Kotanko P, Canaud B, Quiroga B, Villaverde M, Abad S, Vega A, Reque J, Yuste C, Barraca D, Perez de Jose A, Lopez-Gomez JM, Castellano Gasch S, Palomares I, Dominguez J, Ramos R, Schmidt J, Hafer C, Clajus C, Hadem J, Schmidt B, Haller H, Kielstein J, Katagiri M, Kamada Y, Kobayashi N, Moriguchi I, Ito Y, Kamekawa D, Akiyama A, Ishii H, Tanaka S, Kamiya K, Hamazaki N, Kato M, Shimizu R, Hotta K, Masuda T, Veronesi M, Mancini E, Valente F, Righetti F, Brunori G, Santoro A, Bal Z, Tutal E, Erkmen Uyar M, Guliyev O, Sayin B, Sezer S, Mikami S, Hamano T, Tanaka T, Iba O, Toki M, Mikami H, Takamitsu Y, Inoue T, Fujii M, Hirayama A, Ueda A, Watanabe R, Matsui H, Nagano Y, Nagase S, Aoyagi K, Owada S, Tutal E, Bal Z, Erkmen Uyar M, Sayin B, Tot U, Sezer S, Onec K, Erten Y, Pasaoglu O, Ebinc F, Uludag K, Okyay G, Inal S, Pasaoglu H, Deger S, Arinsoy T, Arias-Guillen M, Masso E, Perez E, Herrera P, Romano B, Perez N, Maduell F, Jung YS, Kim YN, Shin HS, Rim H, Al Ismaili Z, Hassan M, Dastoor H, Bernieh B, Ismael A, Marcelli D, Richards N, Khil M, Sheiman B, Dudar I, Gonchar Y, Khil V, Kim HL, Ryu HH, Kim SH, Bosch Benitez-Parodi E, Baamonde Laborda E, Perez Suarez G, Ramirez JI, Garcia Canton C, Guerra R, Ramirez Puga A, Toledo A, Lago Alonso MM, Checa Andres MD, Hwang WM, Yun SR, Molsted S, Andersen JL, Eidemak I, Harrison AP, Kose E, Turgutalp K, Kiykim A, Celik F, Gok Oguz E. Protein-energy wasting. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
107
|
Karasawa K, Machitori Y, Nihei K, Tanaka H, Shimizuguchi T, Murata H, Kageyama S, Chang T, Fujii M. PO-0677: Three dimensional non-coplanar conformal radiotherapy with 75Gy/25fr/5w regimen for the treatment of stage I NSCLC. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)32983-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
108
|
Fujii M, Owari M. Study on the fundamental predominance in shave-off depth profiling. SURF INTERFACE ANAL 2013. [DOI: 10.1002/sia.5044] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
109
|
Inoue Y, Fujisawa M, Kawamoto S, Shoji M, Hashizume S, Fujii M, Katakura Y, Shirahata S. Effectiveness of vitamin A acetate for enhancing the production of lung cancer specific monoclonal antibodies. Cytotechnology 2012; 31:77-83. [PMID: 19003127 DOI: 10.1023/a:1008016020785] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
The antibody productivity of the human-human hybridoma cell line AE6, which produces the lung cancer specific human monoclonal antibody AE6F4, was enhanced fourfold upon stimulation with 1 mug/ml of vitamin A acetate for one day. The enhancement lasted for about two weeks, and could be repeated by another stimulation with vitamin A acetate. The enhancing effect of vitamin A acetate was influenced by the cell density. Enhancement was clearly observed when the cell density was under 10(6) cells/ml. However, when the cell density was over 10(7) cells/ml, enhancement was observed weakly or not at all. Although the enhancing effect of vitamin A acetate is not unique to AE6 cells, not all human-human hybridoma cell lines show increased productivity upon VA acetate stimulation. This study suggests that the response to vitamin A acetate may be related to the properties of a particular fusion partner which the hybridoma cell inherits. The efficacy of vitamin A acetate for production of human monoclonal antibodies using human-human hybridomas is discussed.
Collapse
|
110
|
Mazaki T, Ishii Y, Fujii M, Iwai S, Ishikawa K. Mutations of p53, E-cadherin, alpha- and beta-catenin genes and tyrosine phosphorylation of beta-catenin in human gastric carcinomas. Int J Oncol 2012; 9:579-83. [PMID: 21541555 DOI: 10.3892/ijo.9.3.579] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
We investigated whether dysfunction of p53 and E-cadherin participate in invasiveness and metastasis of human gastric carcinoma. We examined twenty-five human gastric carcinomas for p53, E-cadherin, alpha- and beta-catenin gene alteration by the reverse transcription-polymerase chain reaction-single strand conformation polymorphism (RT-PCR-SSCP) method and sequencing analysis. Three samples (13%) showed p53 gene mutation (two missense mutations and 6 bp deletion). 25% (3/12) of the carcinomas with lymph node metastasis had p53 gene mutations. One sample (4%) showed E-cadherin silent mutation. We were not able to detect alpha- or beta-catenin gene alteration. Therefore we investigated tyrosine-phosphorylation of E-cadherin, a and beta-catenin. Tyrosine-phosphorylated beta-catenin was detected in 13% (2/15) of poorly differentiated carcinomas. These results suggest that the p53 gene mutations have some correlation with lymph node metastasis, and tyrosine phosphorylation of beta-catenin rather than cadherin/catenin gene mutation is at least partly responsible for the loosening of cell-cell contact and invasiveness of poorly differentiated carcinomas.
Collapse
|
111
|
Fujii M, Tahara M, Kiyota N, Mizusawa J, Nakamura K, Hayashi R, Akimoto T, Hasegawa Y, Iwae S, Monden N, Matsuura K, Fujii H, Onozawa Y, Homma A, Kubota A. Phase II Trial of Chemoradiotherapy Concurrent with S-1 Plus Cisplatin in Patients with Unresectable Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Results of the Japan Clinical Oncology Group Study, JCOG 0706. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)32017-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
112
|
Yoshida K, Fujii M, Koizumi W, Kim H, Kim Y, Takeuchi M, Nakajima T. S-1 Plus Docetaxel Versus S-1 for Advanced Gastric Cancer (START TRIAL) Update 2012 (JACCRO AND KCSG STUDY GROUP). Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)34323-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
113
|
Fujii M, Sato Y, Ito H, Masago Y, Omura T. Monosaccharide composition of the outer membrane lipopolysaccharide and O-chain from the freshwater cyanobacterium Microcystis aeruginosa NIES-87. J Appl Microbiol 2012; 113:896-903. [PMID: 22817604 DOI: 10.1111/j.1365-2672.2012.05405.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2012] [Revised: 06/13/2012] [Accepted: 07/12/2012] [Indexed: 11/29/2022]
Abstract
AIMS Bacterial lipopolysaccharide (LPS) protruding from the outermost layer of the outer membrane is expected to play an important role in cell physiology by interacting with molecules in the extracellular milieu; however, the structural and functional characteristics of these components in cyanobacteria remain largely unknown. We isolated water-soluble fractions of LPS and O-chain from the bloom-forming freshwater cyanobacterium Microcystis aeruginosa NIES-87 and identified their monosaccharide compositions. METHODS AND RESULTS SDS-PAGE followed by silver staining demonstrated that the isolated total LPS was the smooth type with different numbers of repeating sugar units in the O-chain region. GC/MS analysis after acid hydrolysis, reduction and acetylation treatments indicated that the neutral monosaccharide components of the total LPS include glucose, rhamnose, mannose, galactose and xylose (in decreasing order of weight percentage), while only glucose was detected in the purified O-chain fraction. MALDI-TOF MS analysis suggested that the O-chain fraction is composed of repeating glucose and methylated glucose disaccharide units. CONCLUSIONS Our results indicate that the monosaccharide composition of M. aeruginosa O-chain is relatively simple. SIGNIFICANCE AND IMPACT OF THE STUDY Although further studies are necessary, these findings provide fundamental information for understanding the structural and functional properties of cyanobacterial LPS and O-chain.
Collapse
|
114
|
Matsukawa H, Shinoda M, Fujii M, Takahashi O, Yamamoto D, Murakata A, Ishikawa R. Factors associated with lobar vs. non-lobar intracerebral hemorrhage. Acta Neurol Scand 2012; 126:116-21. [PMID: 22067041 DOI: 10.1111/j.1600-0404.2011.01615.x] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
OBJECTIVES The relationship between body mass index (BMI) and stroke subtypes has received more research attention than that between BMI and location of intracerebral hemorrhage (ICH). Lobar hemorrhage (LH) differs from non-LH primarily in terms of etiology, i.e. cerebral amyloid angiopathy is the main cause of LH. This study aimed to determine the relationship between BMI and ICH. MATERIALS AND METHODS In this retrospective study involving 460 consecutive patients with ICH, BMI was significantly lower in LH than for other ICH locations. BMI categories were underweight (BMI < 18.5 kg/m(2)), normal weight (18.5-23.0 kg/m(2)), overweight (23.0-27.5 kg/m(2)), or obesity (≥27.5 kg/m(2)). Outcome at 1 year was evaluated by the modified Rankin Scale (mRS). We investigated the relationship of BMI and other clinical characteristics with LH and non-LH. RESULTS LH was associated with age (>70 years), underweight, unfavorable outcome (mRS ≥3), and daily alcohol consumption. Hypertension and intraventricular bleeding were significantly less common in patients with LH than those with non-LH. CONCLUSIONS Alongside risk factors conventionally thought to be related to LH, underweight may also be a LH-related factor, specifically in the elderly.
Collapse
|
115
|
Fujii M, Bessho R, Ochi M, Shimizu K, Terajima K, Takeda S. Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery. THE JOURNAL OF CARDIOVASCULAR SURGERY 2012; 53:369-374. [PMID: 22249647] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
AIM Atrial fibrillation is one of the most common postoperative arrhythmias following cardiac surgery. Despite many clinical studies, there is still no consensus on the most appropriate prevention strategy for atrial arrhythmia. A randomized prospective trial was conducted to determine the efficacy of intravenous landiolol administration in the early period after off-pump coronary artery bypass grafting (CABG) followed by treatment with carvedilol for prevention of atrial fibrillation. METHODS Seventy consecutive patients were enrolled in the study prospectively. Patients in the treated group received landiolol intravenously (5 μg/kg/min) in the ICU immediately after surgery. Heart rate was maintained at 60-80 bpm and intravenous landiolol was continued at 0-10 μg/kg/min until oral drug administration was possible. All patients received oral carvedilol (2.5-5 mg/day) after extubation and this was continued postoperatively. The primary endpoint was the overall development of postoperative atrial fibrillation. RESULTS Postoperative atrial fibrillation occurred in 4 (11.1%) of the 36 patients in the landiolol group, compared with 11 (32.3%) of the 34 patients in the control group, indicating that development of atrial fibrillation was significantly inhibited by landiolol (P=0.042). No major postoperative complications occurred in the landiolol group. CONCLUSION Postoperative intravenous landiolol therapy followed by oral carvedilol may be more effective than oral carvedilol alone for prevention of atrial fibrillation after off-pump CABG. We also found that intravenous landiolol is well tolerated after cardiac surgery.
Collapse
|
116
|
Adamczak M, Wiecek A, Nowak L, Grzegorzewska AE, Niepolski L, Pajzderski D, Mohamed WAAA, Mohamed WAAA, Khamis Zaki FM, Bekhit WHM, Sherif IS, Lin CC, Chen HY, Chiu YL, Hsu SP, Pai MF, Yang JY, Peng YS, Tsai TJ, Wu KD, Shojai S, Udayaraj U, Shojai P, Zwiech R, Bruzda-Zwiech A, Musial K, Zwolinska D, Grzegorzewska AE, Piotr M. W, Mostowska A, Jagodzinski PP, Ortalda V, Tomei P, Yabarek T, Tobaldini O, Gangemi C, Messa MG, Lupo A, Ebah L, Nikam M, Summers A, Dawidowska I, Jayanti A, Wiig H, Brenchley P, Mitra S, Mikami S, Hamano T, Iba O, Toki M, Mikami H, Takamitsu Y, Fujii M, Dzekova-Vidimliski P, Sikole A, Gelev S, Selim G, Trajceska L, Fujimoto S, Inagaki H, Fukudome K, Ebihara F, Yokota N, Sato Y, Akiba T, Otsubo S, Nitta K, Rydzewska-Rosolowska A, Gozdzikiewicz J, Borawski J, Hryszko T, Koc-Zorawska E, Mysliwiec M, Arias M, Arias M, Banon-Maneus E, Sole A, Hierro-Garcia N, Rovira J, Ramirez-Bajo MJ, Quintana LF, Diekmann F, Moya-Rull D, Maduell F, Campistol JM, Erkmen Uyar M, Toprak SK, Saglam H, Tutal E, Bay M, Ilhan O, Sezer S, Malyszko J, Malyszko J, Kozminski P, Koc-Zorawska E, Zbroch E, Mysliwiec M. Pathophysiology CKD 5D. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs246] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
117
|
Konoshita T, Ichikawa M, Kimura T, Sato S, Fujii M, Makino Y, Wakahara S, Miyamori I, Svensson M, Cederholm J, Eliasson B, Zethelius B, Gudbjornsdottir S, Porrini E, Ruggenenti P, Motterlini N, Perna A, Parvanova Ilieva A, Petrov Iliev I, Dodesini AR, Bossi A, Sampietro G, Capitoni E, Gaspari F, Rubis N, Gherardi G, Ene-Iordache B, Remuzzi G, Tsuda A, Ishimura E, Ohno Y, Ichii M, Nakatani S, Mori K, Inaba M, Ge Y, Xie H, LI S, Jin B, Hou J, Zhang H, Shi M, Liu Z, Simone S, Cariello M, Vavallo A, Loverre A, Ranieri E, Battaglia M, Ditonno P, Gesualdo L, Grandaliano G, Pertosa G. Diabetes clinical studies. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
118
|
Mizuno T, Murakami H, Fujii M, Ishiguro F, Tanaka I, Kondo Y, Akatsuka S, Toyokuni S, Yokoi K, Osada H, Sekido Y. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes. Oncogene 2012; 31:5117-22. [PMID: 22286761 DOI: 10.1038/onc.2012.5] [Citation(s) in RCA: 195] [Impact Index Per Article: 16.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Malignant mesothelioma (MM) shows frequent inactivation of the neurofibromatosis type 2 (NF2) -tumor-suppressor gene. Recent studies have documented that the Hippo signaling pathway, a downstream cascade of Merlin (a product of NF2), has a key role in organ size control and carcinogenesis by regulating cell proliferation and apoptosis. We previously reported that MMs show overexpression of Yes-associated protein (YAP) transcriptional coactivator, the main downstream effector of the Hippo signaling pathway, which results from the inactivation of NF2, LATS2 and/or SAV1 genes (the latter two encoding core components of the mammalian Hippo pathway) or amplification of YAP itself. However, the detailed roles of YAP remain unclear, especially the target genes of YAP that enhance MM cell growth and survival. Here, we demonstrated that YAP-knockdown inhibited cell motility, invasion and anchorage-independent growth as well as cell proliferation of MM cells in vitro. We analyzed genes commonly regulated by YAP in three MM cell lines with constitutive YAP-activation, and found that the major subsets of YAP-upregulating genes encode cell cycle regulators. Among them, YAP directly induced the transcription of CCND1 and FOXM1, in cooperation with TEAD transcription factor. We also found that knockdown of CCND1 and FOXM1 suppressed MM cell proliferation, although the inhibitory effects were less evident than those of YAP knockdown. These results indicate that constitutive YAP activation in MM cells promotes cell cycle progression giving more aggressive phenotypes to MM cells.
Collapse
|
119
|
Fujii M, Nakashima Y, Yamamoto T, Mawatari T, Motomura G, Iwamoto Y, Noguchi Y. Effect of intra-articular lesions on the outcome of periacetabular osteotomy in patients with symptomatic hip dysplasia. ACTA ACUST UNITED AC 2011; 93:1449-56. [DOI: 10.1302/0301-620x.93b11.27314] [Citation(s) in RCA: 75] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
In order to clarify how intra-articular lesions influence the survival of a periacetabular osteotomy in patients with dysplasia of the hip, we performed an observational study of 121 patients (121 hips) who underwent a transposition osteotomy of the acetabulum combined with an arthroscopy. Their mean age was 40.2 years (13 to 64) and the mean follow-up was 9.9 years (2 to 18). Labral and cartilage degeneration tended to originate from the anterosuperior part of the acetabulum, followed by the femoral side. In all, eight hips (6.6%) had post-operative progression to Kellgren–Lawrence grade 4 changes, and these hips were associated with the following factors: moderate osteoarthritis, decreased width of the joint space, joint incongruity, and advanced intra-articular lesions (subchondral bone exposure in the cartilage and a full-thickness labral tear). Multivariate analysis indicated subchondral bone exposure on the femoral head as an independent risk factor for progression of osteoarthritis (p = 0.003). In hips with early stage osteoarthritis, femoral subchondral bone exposure was a risk factor for progression of the grade of osteoarthritis. Although the outcome of transposition osteotomy of the acetabulum was satisfactory, post-operative progression of osteoarthritis occurred at a high rate in hips with advanced intra-articular lesions, particularly in those where the degenerative process had reached the point of femoral subchondral bone exposure.
Collapse
|
120
|
Fujii M, Honma M, Takahashi H, Ishida-Yamamoto A, Iizuka H. The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma. Clin Exp Dermatol 2011; 36:788-92. [PMID: 21883393 DOI: 10.1111/j.1365-2230.2011.04118.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND Distinguishing keratoacanthoma (KA) from well-differentiated squamous cell carcinoma (SCC) is sometimes difficult. Recent evidence indicates that the nuclear factor kappa B p50 subunit (p50) and cortactin might be useful to distinguish between these two conditions. AIM To verify whether p50 and cortactin are useful differentiation markers to distinguish between subungual KA and well-differentiated SCC. METHODS Immunohistochemistry using p50, cortactin and Ki-67 was performed on 20 patients with KA and 20 patients with facial well-differentiated SC. Ki-67 staining was also evaluated and scored. RESULTS Both p50 and cortactin had higher levels of expression in KA than in SCC. Both were localized to the basal-cell layer of KA, whereas they were scattered without polarity throughout the SCC lesions. Although the Ki-67 index was not significantly different between KA and SCC, the staining pattern also showed loss of polarity in SCC. CONCLUSION p50 and cortactin might be useful makers to distinguish between KA and well-differentiated SCC.
Collapse
|
121
|
Kato H, Kawamoto H, Yamamoto K, Noma Y, Sonoyama T, Tsutsumi K, Fujii M, Kurihara N, Okada H. A newly designed plastic stent for multiple occluded metallic stents deployed in malignant hilar biliary strictures. Endoscopy 2011; 43 Suppl 2 UCTN:E225-6. [PMID: 21614756 DOI: 10.1055/s-0030-1256318] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/10/2022]
|
122
|
Ikeda N, Inoguchi T, Sonoda N, Fujii M, Takei R, Hirata E, Yokomizo H, Zheng J, Maeda Y, Kobayashi K, Takayanagi R. Biliverdin protects against the deterioration of glucose tolerance in db/db mice. Diabetologia 2011; 54:2183-91. [PMID: 21614569 DOI: 10.1007/s00125-011-2197-2] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/12/2010] [Accepted: 04/12/2011] [Indexed: 01/11/2023]
Abstract
AIMS/HYPOTHESIS We have previously shown a negative correlation between serum bilirubin levels and prevalence of type 2 diabetes, suggesting that bilirubin inhibits development of this disease. To confirm this hypothesis, we investigated whether administration of biliverdin, the precursor of bilirubin, protects against the deterioration of glucose tolerance in db/db mice, a rodent model of type 2 diabetes. METHODS Biliverdin (20 mg/kg daily) was orally administered to 5-week-old db/db mice for 4 weeks. After 4 weeks of treatment, i.p. glucose tolerance and insulin tolerance tests were performed. Insulin content was evaluated by immunostaining and ELISA. Oxidative stress markers (8-hydroxy-2'-deoxyguansosine and dihydroethidium staining) and expression of NADPH oxidase components Pdx1 and Bax were also evaluated in isolated islets. RESULTS Treatment with biliverdin partially prevented worsening of hyperglycaemia and glucose intolerance in db/db mice. This effect was accompanied by a significant increase in insulin content and Pdx1 expression, and a significant decrease of apoptosis and Bax expression in pancreatic islets from db/db mice. At the same time, levels of oxidative stress markers and NADPH oxidase component production in islets were normalised. Biliverdin had little effect on HOMA of insulin resistance or insulin resistance evaluated by insulin tolerance tests. CONCLUSIONS/INTERPRETATION Biliverdin may protect against progressive worsening of glucose tolerance in db/db mice, mainly via inhibition of oxidative stress-induced beta cell damage.
Collapse
|
123
|
Uchihashi Y, Hosoda K, Zimine I, Fujita A, Fujii M, Sugimura K, Kohmura E. Clinical application of arterial spin-labeling MR imaging in patients with carotid stenosis: quantitative comparative study with single-photon emission CT. AJNR Am J Neuroradiol 2011; 32:1545-51. [PMID: 21757531 DOI: 10.3174/ajnr.a2525] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE Arterial spin-labeling is an emerging technique for noninvasive measurement of cerebral perfusion, but concerns remain regarding the reliability of CBF quantification and clinical applications. Recently, an ASL implementation called QUASAR was proposed, and it was shown to have good reproducibility of CBF assessment in healthy volunteers. This study aimed to determine the utility of QUASAR for CBF assessment in patients with cerebrovascular diseases. MATERIALS AND METHODS Twenty patients with carotid stenosis underwent CBF quantification by ASL (QUASAR) within 3 days of performance of (123)I-iodoamphetamine-SPECT. CVR to acetazolamide also was assessed by ASL and SPECT. In surgically treated patients, the respective scans before and after the procedures were compared. RESULTS Regional CBF and CVR values measured by ASL were significantly correlated and agreed with those measured by SPECT (r(s) = 0.92 and 0.88, respectively). A Bland-Altman plot demonstrated good agreement between 2 methods in terms of CBF quantification. Furthermore, ASL could detect pathologic states such as hypoperfusion, impaired vasoreactivity, and postoperative hyperperfusion, equivalent to SPECT. However, ASL tended to overestimate CBF values especially in high-perfusion regions. CONCLUSIONS ASL perfusion MR imaging is clinically applicable and can be an alternative method for CBF assessment in patients with cerebrovascular diseases.
Collapse
|
124
|
Takahashi K, Shibasaki A, Hirose T, Kaneko K, Nakamura M, Ohba K, Kato I, Totsune K, Zumrutdal A, Calayoglu R, Mescigil P, Kutlay S, Sengul S, Erturk S, Ibrahim M, Ahmed T, Awadalla A, El Naggar A, Yokoyama T, Onodera Y, Shimonaka Y, Sasaki Y, Kuragano T, Furuta M, Kida A, Kitamura R, Yahiro M, Otaki T, Hasuike Y, Nonoguchi H, Nishihara F, Nakanishi T, Sedlackova T, Racek J, Trefil L, Eiselt J, Kielberger L, Malanova L, Youssef D, Tawfeek D, Desoki T, Khalifa N, Takasawa K, Takaeda C, Higuchi M, Maeda T, Tomosugi N, Bratescu LO, Barsan L, Garneata L, Stanciu A, Lipan M, Stancu SH, Mircescu G, Zager P, Paine S, Myers O, Chang JH, Jung JY, Lee HH, Chung W, Kim S, Tutal E, Erkmen Uyar M, Sezer S, Bal Z, Wabel P, Machek P, Moissl U, Chamney P, Jirka T, Moissl U, Wabel P, Chamney P, Wieskotten S, Amato C, Mari F, Korol L, Dudar I, Van Wyck D, Goykhman I, Weldon J, Krishnan M, Nissenson A, Kinugasa E, Sanaka T, Mochizuki T, Kuno T, Kojima K, Kobayashi S, Satoh M, Noiri E, Kusano E, Owada S, Shimada N, Nakao K, Nakazawa R, Nishimura H, Tomo T, Shigematsu T, Maeda T, Rottembourg J, Guerin A, Diaconita M, Dumont JC, Dansaert A, Chailimpamontree W, Gojaseni P, Pajareya T, Chittinandana A, Bachmakov I, Meissner R, Benkenstein C, Migliori M, Bernabini G, Beati S, Paoletti S, De Pietro S, Ferrandello FP, Panichi V, Senol E, Ersoy A, Erdinc S, Sarandol E, Mikami S, Hamano T, Iba O, Inoue T, Toki M, Takamitsu Y, Mikami H, Fujii M. Anaemia in CKD 5D. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.56] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
125
|
Miura D, Fujii M, Iwatani T, Takano T, Kawabata H. Reduction of toxicity by reversing the order of infusion in docetaxel and cyclophosphamide (TC). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.2576] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|